Prenetics signs Lily Collins as IM8 ambassador, raises revenue guidance
The consumer health company added its first film and television ambassador as it lifted 2026 revenue guidance and issued a first 2027 forecast.
Prenetics Global Limited announced on August 20, 2026 a multi-year partnership making actress and producer Lily Collins a global ambassador for IM8, its health and longevity brand co-founded with David Beckham. Collins becomes a Global Ambassador of IM8 and a shareholder in Prenetics, demonstrating her long-term conviction in the brand and the Company.1 The partnership formalizes a relationship that began when Collins was introduced to IM8 Daily Ultimate Essentials by her physician while filming in late 2025.1
Collins connects with more than 33 million people across social platforms, including more than 28 million on Instagram, with an engagement rate of roughly 5.9%, several times the 1–2% typical of accounts at comparable scale.1 She joins a roster that includes David Beckham, Giannis Antetokounmpo, Aryna Sabalenka, Ollie Bearman, Jay Shetty, and Inter Miami CF, and takes equity in Prenetics as part of the partnership, making her IM8's first ambassador from film and television and the first whose primary audience is female.1
On the business side, since launching in December 2024, IM8 has delivered more than 57 million servings, currently ships about 200,000 servings a day, receives an order every 27 seconds, and ships to 46 countries, with 54% of revenue generated outside the United States.1 The company's pipeline includes IM8 Hydration launching in Q4 2026 and a premium gummies line in the first half of 2027.1
Prenetics raised its full-year 2026 revenue guidance to $220–$230 million and initiated guidance of $400 million or more for full-year 2027 revenue.1 The company said it achieved positive consolidated Adjusted Free Cash Flow in July 2026 and expects to remain positive on that measure for the full third quarter of 2026 and beyond.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.